C12Q 1/48
Involving transferase
Official title: involving transferase
C12Q1/48 (Involving transferase) appears on 2,039 US grants and 3,184 published applications in this corpus.
Search patents in C12Q- Granted patents
- 2,039
- Published applications
- 3,184
- Assignees
- 1,458
- Inventors
- 6,977
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 14 | 0 |
| 1978 | 9 | 0 |
| 1979 | 3 | 0 |
| 1980 | 11 | 0 |
| 1981 | 15 | 0 |
| 1982 | 13 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 9 | 0 |
| 1986 | 12 | 0 |
| 1987 | 12 | 0 |
| 1988 | 15 | 0 |
| 1989 | 13 | 0 |
| 1990 | 13 | 0 |
| 1991 | 11 | 0 |
| 1992 | 14 | 0 |
| 1993 | 15 | 0 |
| 1994 | 15 | 0 |
| 1995 | 18 | 0 |
| 1996 | 26 | 0 |
| 1997 | 24 | 0 |
| 1998 | 44 | 0 |
| 1999 | 49 | 0 |
| 2000 | 48 | 0 |
| 2001 | 59 | 16 |
| 2002 | 55 | 121 |
| 2003 | 55 | 200 |
| 2004 | 60 | 147 |
| 2005 | 44 | 181 |
| 2006 | 60 | 180 |
| 2007 | 69 | 159 |
| 2008 | 73 | 154 |
| 2009 | 65 | 153 |
| 2010 | 94 | 169 |
| 2011 | 71 | 131 |
| 2012 | 81 | 115 |
| 2013 | 86 | 133 |
| 2014 | 79 | 136 |
| 2015 | 75 | 105 |
| 2016 | 58 | 109 |
| 2017 | 68 | 105 |
| 2018 | 77 | 96 |
| 2019 | 59 | 82 |
| 2020 | 68 | 85 |
| 2021 | 52 | 90 |
| 2022 | 51 | 78 |
| 2023 | 38 | 79 |
| 2024 | 38 | 103 |
| 2025 | 52 | 131 |
| 2026 | 28 | 126 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition and methods related to modification of 5 hydroxymethylcytosine (5-hmC)6 Oct 2026US 12,753,445 B2The University of Chicago
- Gene conferring resistance to fungal pathogen29 Sep 2026US 12,747,450 B2KWS SAAT SE & Co. KGaA
- Marine DNA polymerase I15 Sep 2026US 12,735,736 B2Universitetet I Tromso—Norges Arktiske Universitet
- Method for quantitative monitoring mRNA capping efficiency8 Sep 2026US 12,729,396 B2Thermo Finnigan LLC
- Medicament for improving or preventing symptoms relating to retina and/or light reception and method for screening for substance capable of improving or preventing symptoms relating to retina and/or light reception4 Aug 2026US 12,697,367 B2Osaka University
- Method for analyzing activity of nucleic acid polymerase using self-dimer primer8 Oct 2026US 2026/0308660 A1Seegene, Inc.
- Methods for preserving methylation status during clustering8 Oct 2026US 2026/0308669 A1Illumina, Inc.
- Plasmonic nanoantenna and use of same in single molecule sequencing8 Oct 2026US 2026/0308679 A1Swan Genomics Pty Ltd
- Detection of tumor-derived nucleic acids using red blood cells8 Oct 2026US 2026/0308689 A1
- Multi-target drug conjugate and use thereof for cancer treatment1 Oct 2026US 2026/0295061 A1Virginia Tech Intellectual Properties, Inc.
Most cited
By later US patents
- Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthase, production and use346US 4,769,061 ACalgene, Inc. · 1988
- Pyrophosphate-based method and apparatus for sequencing nucleic acids282US 4,971,903 A1990
- Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthetase, production and use250US 4,535,060 ACalgene, Inc. · 1985
- Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems228US 4,824,941 A1989
- Methods and apparatus for detecting nucleic acid polymorphisms185US 6,297,018 B1LJL BioSystems, Inc. · 2001